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Background
Questionnaires are essential for measurement of tinnitus
severity and treatment-related change. Yet no standard
measure is used across clinical and research settings.
Current tinnitus questionnaires are limited to measuring
severity or change, but not both [1,2]. The Tinnitus
Functional Index (TFI) was developed as both a diagnos-
tic measure of the functional impact of tinnitus and to be
a sensitive measure of treatment-related change [3]. It
has not, however, been fully validated. This present study
evaluates the validity of the TFI as a diagnostic measure
of tinnitus severity in a UK research population.
Methods
The study involved a retrospective analysis of data col-
lected for 294 participants who had previously partici-
pated in a randomised controlled trial of a novel
tinnitus device [4]. Participants completed a series of
questionnaires including the TFI, Tinnitus Handicap
Inventory (THI) [5], Tinnitus Handicap Questionnaire
(THQ) [6], a Visual Analogue Scale of Loudness (VAS-
L) [7], a Percentage Rating of Annoyance (PR-A), Beck’s
Depression Inventory (BDI) [8], Beck’s Anxiety Inven-
tory (BAI) [9], and the World Health Organisation
Quality of Life Bref (WHOQOL) [10]. Forty four partici-
pants, who completed the TFI at a second visit (within
21 days), provided data for reliability assessment.
Psychometric analyses included (1) Confirmatory factor
analysis (CFA) using the current eight subscales
proposed for the TFI development; (2) Convergent and
discriminant validity; and (3) Test-retest reliability and
agreement.
Results
The TFI structure showed acceptable model fit (RMSEA =
0.65), although it was not optimal. The auditory factor in
particular was unrelated to the other factors and the
underlying construct of “the functional impact of tinnitus
on daily life”. Acceptable convergent and discriminant
validity was demonstrated by the high correlations
between the scores on the TFI and THI (r = 0.82) and
THQ (r = 0.82), moderate correlations with VAS-L (r =
0.46), PR-A (r = 0.58), BDI (r = 0.57), BAI (r = 0.38) and
WHOQOL (r = -0.48). Reliability assessments indicated
high test-retest reliability for the TFI global scores (ICC =
0.86) and borderline acceptable test-retest agreement for
the TFI global scores (93%).
Conclusion
The TFI does cover multiple symptom domains and
provides a valid measure of tinnitus that can reliably
distinguish between individuals in this population. The
proposed 8-factor structure, however, was not fully con-
firmed. Given these results, it may be more appropriate
to view each subscale individually rather the combining
the subscales to create a global score. Further investiga-
tion of the TFI structure and sensitivity to treatment-
related change is warranted.
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